Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug;53(8):676-81.
doi: 10.1007/s00117-013-2499-0.

[Potential of PET/MRI for diagnosis of prostate cancer]

[Article in German]
Affiliations

[Potential of PET/MRI for diagnosis of prostate cancer]

[Article in German]
M C Röthke et al. Radiologe. 2013 Aug.

Abstract

Clinical/methodical issue: A present goal is to improve detection and staging of prostate cancer using innovative imaging technology such as PET/MRI.

Standard radiological methods: The modality of choice for detection of prostate cancer is multiparametric MRI. Furthermore, PET/CT is used, in particular, for the detection and staging of distant metastases and recurrent disease. For assessment of bone metastases, the method most commonly used is bone scintigraphy.

Methodical innovations: The development of a simultaneous hybrid PET/MRI system is the last great "fusion" of the known cross-sectional image modalities. In addition, synthesis of new, innovative tracers such as (18)F-FACBC or (68)Ga-PSMA allows more specific detection of prostate cancer.

Performance: Hybrid PET/MRI imaging has the potential to replace conventional imaging techniques in the future.

Achievements: The method is just starting the broad application. Clinical studies must be expanded in order to substantiate the additional value of the method.

Practical recommendations: Currently, there is still a low distribution situation, since it is a new and cost-intensive method. At the same time, there is still no consistent solution for reimbursement. The importance in practice first rises by clarifying the payment situation and further demonstration of the method's benefit by larger studies.

PubMed Disclaimer

References

    1. Eur Urol. 2013 Jun;63(6):1040-8 - PubMed
    1. Eur J Nucl Med Mol Imaging. 2013 May;40(5):799 - PubMed
    1. Clin Radiol. 2008 Jul;63(7):774-82 - PubMed
    1. Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1567-9; author reply 1570 - PubMed
    1. Nat Rev Urol. 2010 Oct;7(10):543-51 - PubMed

Publication types

LinkOut - more resources